Primary experimental recordNegative / threshold

PMC12839123::ACT034833

C-CR5

Evidence text

Paper-level observation

As a result of treating the RAW 264.7 macrophages with L-CR5 and C-CR5 at a concentration of 6.25–400 μg/mL, cell viability was maintained at 95% or more in all treatment groups.

textConfidence: medium

Assay observation

Activity

Toxicity

Subtype

Cytotoxic

Measure

cell_viability

Comparator

Raw observation

≥95%

Normalized measurement

>=95%

Value minimum

Not reported by source

Value maximum

Not reported by source

Target

RAW 264.7

Assay method

Not reported by source

Sequence

CYGSR

Standardization

ready simple

Source publication

Comparison of In Vitro Multiple Physiological Activities of Cys–Tyr–Gly–Ser–Arg (CYGSR) Linear and Cyclic Peptides and Analysis Based on Molecular Docking

Biomolecules · 2026

DOI 10.3390/biom16010126 PMC12839123

Parent mention

Related peptide identities

PEPDIA-PLP-000379

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.